154 related articles for article (PubMed ID: 10897169)
21. Mechanism of action of the anticonvulsant felbamate: opposing effects on N-methyl-D-aspartate and gamma-aminobutyric acidA receptors.
Sofia RD
Ann Neurol; 1994 Oct; 36(4):677-8. PubMed ID: 7944305
[No Abstract] [Full Text] [Related]
22. Role of new and established antiepileptic drugs.
Leppik IE
Epilepsia; 1998; 39 Suppl 5():2-6. PubMed ID: 9737436
[No Abstract] [Full Text] [Related]
23. Anticonvulsant effect of felbamate in the pentylenetetrazole kindling model of epilepsy in the rat.
Giorgi O; Carboni G; Frau V; Orlandi M; Valentini V; Feldman A; Corda MG
Naunyn Schmiedebergs Arch Pharmacol; 1996 Jul; 354(2):173-8. PubMed ID: 8857594
[TBL] [Abstract][Full Text] [Related]
24. Voltage-activated calcium channels: targets of antiepileptic drug therapy?
Stefani A; Spadoni F; Bernardi G
Epilepsia; 1997 Sep; 38(9):959-65. PubMed ID: 9579933
[TBL] [Abstract][Full Text] [Related]
25. Felbamate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in epilepsy.
Palmer KJ; McTavish D
Drugs; 1993 Jun; 45(6):1041-1065. PubMed ID: 7691493
[TBL] [Abstract][Full Text] [Related]
26. Interaction of felbamate with [3H]DCKA-labeled strychnine-insensitive glycine receptors in human postmortem brain.
Wamsley JK; Sofia RD; Faull RL; Narang N; Ary T; McCabe RT
Exp Neurol; 1994 Oct; 129(2):244-50. PubMed ID: 7957739
[TBL] [Abstract][Full Text] [Related]
27. Felbamate overdose: a case report and discussion of a new antiepileptic drug.
Nagel TR; Schunk JE
Pediatr Emerg Care; 1995 Dec; 11(6):369-71. PubMed ID: 8751173
[TBL] [Abstract][Full Text] [Related]
28. Electrophysiological actions of felbamate on rat striatal neurones.
Pisani A; Stefani A; Siniscalchi A; Mercuri NB; Bernardi G; Calabresi P
Br J Pharmacol; 1995 Oct; 116(3):2053-61. PubMed ID: 8640345
[TBL] [Abstract][Full Text] [Related]
29. Effects of the antiepileptic drug felbamate on long-term potentiation in the CA1 region of rat hippocampal slices.
Pugliese AM; Corradetti R
Neurosci Lett; 1996 Aug; 215(1):21-4. PubMed ID: 8880744
[TBL] [Abstract][Full Text] [Related]
30. Interactions of MRZ 2/576 with felbamate, lamotrigine, oxcarbazepine and topiramate in the mouse maximal electroshock-induced seizure model.
Luszczki JJ; Danysz W; Czuczwar SJ
Pharmacology; 2008; 81(3):259-65. PubMed ID: 18253065
[TBL] [Abstract][Full Text] [Related]
31. The use of felbamate in the treatment of patients with intractable epilepsy.
Benbadis S
Neurology; 2000 Mar; 54(5):1206. PubMed ID: 10720307
[No Abstract] [Full Text] [Related]
32. Molecular determinants of the anticonvulsant felbamate binding site in the N-methyl-D-aspartate receptor.
Chang HR; Kuo CC
J Med Chem; 2008 Mar; 51(6):1534-45. PubMed ID: 18311896
[TBL] [Abstract][Full Text] [Related]
33. Gabapentin interaction with felbamate.
Hussein G; Troupin AS; Montouris G
Neurology; 1996 Oct; 47(4):1106. PubMed ID: 8857758
[No Abstract] [Full Text] [Related]
34. A neuropharmacological evaluation of felbamate as a novel anticonvulsant.
White HS; Wolf HH; Swinyard EA; Skeen GA; Sofia RD
Epilepsia; 1992; 33(3):564-72. PubMed ID: 1592038
[TBL] [Abstract][Full Text] [Related]
35. [Felbamate: perspectives for new antiepileptic treatment].
Pérez-Miranda J; Aguirre J; Parrilla JL; Pérez Miranda M
Rev Neurol; 1995; 23(124):1220-5. PubMed ID: 8556622
[TBL] [Abstract][Full Text] [Related]
36. [The pharmacologic and clinical profile of the new anticonvulsant felbamate--an overview].
Steinhoff BJ
Fortschr Neurol Psychiatr; 1994 Oct; 62(10):379-88. PubMed ID: 8001894
[TBL] [Abstract][Full Text] [Related]
37. Felbamate in experimental model of status epilepticus.
Mazarati AM; Baldwin RA; Sofia RD; Wasterain CG
Epilepsia; 2000 Feb; 41(2):123-7. PubMed ID: 10691107
[TBL] [Abstract][Full Text] [Related]
38. Electrophysiological effects of felbamate.
Corradetti R; Pugliese AM
Life Sci; 1998; 63(13):1075-88. PubMed ID: 9763203
[TBL] [Abstract][Full Text] [Related]
39. Practice advisory: The use of felbamate in the treatment of patients with intractable epilepsy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society.
French J; Smith M; Faught E; Brown L
Neurology; 1999 May; 52(8):1540-5. PubMed ID: 10331676
[No Abstract] [Full Text] [Related]
40. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy.
Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L
Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
